ALMDT Stock Overview
Develops and markets software products and platforms for medical image analysis in France, the United States, Canada, the United Kingdom, China, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 1/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
+ 1 more risk
My Notes
Capture your thoughts, links and company narrative
Median Technologies SA Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €3.67 |
| 52 Week High | €7.76 |
| 52 Week Low | €2.00 |
| Beta | 1.49 |
| 1 Month Change | -2.13% |
| 3 Month Change | -18.54% |
| 1 Year Change | -26.60% |
| 3 Year Change | -75.89% |
| 5 Year Change | 86.29% |
| Change since IPO | -63.59% |
Recent News & Updates
It's Down 28% But Median Technologies SA (EPA:ALMDT) Could Be Riskier Than It Looks
Dec 03
Revenues Tell The Story For Median Technologies SA (EPA:ALMDT) As Its Stock Soars 72%
Aug 30Recent updates
It's Down 28% But Median Technologies SA (EPA:ALMDT) Could Be Riskier Than It Looks
Dec 03Revenues Tell The Story For Median Technologies SA (EPA:ALMDT) As Its Stock Soars 72%
Aug 30Slammed 28% Median Technologies SA (EPA:ALMDT) Screens Well Here But There Might Be A Catch
Jun 30Investors Give Median Technologies SA (EPA:ALMDT) Shares A 28% Hiding
Mar 14Median Technologies SA (EPA:ALMDT) Looks Just Right With A 26% Price Jump
Jan 03Newsflash: Median Technologies SA (EPA:ALMDT) Analysts Have Been Trimming Their Revenue Forecasts
Jul 14Median Technologies SA (EPA:ALMDT) Might Not Be As Mispriced As It Looks After Plunging 46%
May 05Is Median Technologies (EPA:ALMDT) Using Too Much Debt?
May 07Announcing: Median Technologies (EPA:ALMDT) Stock Increased An Energizing 254% In The Last Year
Dec 28Shareholder Returns
| ALMDT | FR Healthcare Services | FR Market | |
|---|---|---|---|
| 7D | -6.1% | -0.5% | -1.7% |
| 1Y | -26.6% | 11.2% | -4.8% |
Return vs Industry: ALMDT underperformed the French Healthcare Services industry which returned 11.1% over the past year.
Return vs Market: ALMDT underperformed the French Market which returned -4.9% over the past year.
Price Volatility
| ALMDT volatility | |
|---|---|
| ALMDT Average Weekly Movement | 9.8% |
| Healthcare Services Industry Average Movement | 6.1% |
| Market Average Movement | 4.5% |
| 10% most volatile stocks in FR Market | 9.7% |
| 10% least volatile stocks in FR Market | 2.3% |
Stable Share Price: ALMDT's share price has been volatile over the past 3 months compared to the French market.
Volatility Over Time: ALMDT's weekly volatility has decreased from 15% to 10% over the past year, but is still higher than 75% of French stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2002 | 250 | Fredrik Brag | www.mediantechnologies.com |
Median Technologies SA develops and markets software products and platforms for medical image analysis in France, the United States, Canada, the United Kingdom, China, and internationally. The company offers iBiops, an end-to-end AI-powered technology software as a medical device for early diagnosis of cancers and fibrotic diseases; iSee for image analysis services in clinical trials; and iCRO, which engages in the sale of imaging services for clinical trials in oncology using software. The company was founded in 2002 and is based in Valbonne, France.
Median Technologies SA Fundamentals Summary
| ALMDT fundamental statistics | |
|---|---|
| Market cap | €67.74m |
| Earnings (TTM) | -€25.35m |
| Revenue (TTM) | €22.32m |
3.0x
P/S Ratio-2.7x
P/E RatioIs ALMDT overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ALMDT income statement (TTM) | |
|---|---|
| Revenue | €22.32m |
| Cost of Revenue | €24.67m |
| Gross Profit | -€2.34m |
| Other Expenses | €23.01m |
| Earnings | -€25.35m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -1.37 |
| Gross Margin | -10.51% |
| Net Profit Margin | -113.57% |
| Debt/Equity Ratio | -138.8% |
How did ALMDT perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/20 18:34 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Median Technologies SA is covered by 10 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Maria Vara Fernández | Bryan Garnier & Co |
| Dylan van Haaften | Bryan Garnier & Co |
| Khalid Deojee | Bryan Garnier & Co |